Noxafil 40 Mg/Ml Oral Suspension 40 mg/mL Oral Suspension
PDF Leaflet Revision Date: 14 October 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of refractory fungal infections and prophylaxis in high-risk patients.
Dosage (summary)
Loading dose of 300 mg twice daily on Day 1, then 300 mg once daily for maintenance.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding due to potential risks.
Key Drug Interactions
- CYP3A4 inhibitors
- Ergot alkaloids
- HMG-CoA reductase inhibitors
Contraindications
- Hypersensitivity to posaconazole
Common side effects
- Nausea
- Diarrhoea
- Dizziness
- Elevated liver enzymes
Counselling Points
- Take with food for oral suspension
- Monitor for liver function
- Avoid certain drug combinations
Serious warnings
- QT prolongation
- Hepatic toxicity
- Vincristine toxicity
Important Disclaimer
The Noxafil 40 Mg/Ml Oral Suspension 40 mg/mL Oral Suspension professional information leaflet below is the property of Msd and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
